HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in articular synovial lining volume measured by magnetic resonance in a randomized, double-blind, controlled trial of intra-articular samarium-153 particulate hydroxyapatite for chronic knee synovitis.

AbstractOBJECTIVE:
Magnetic resonance techniques have recently been investigated as tools with which to monitor inflammatory joint disease. Our aim was to use a contrast-enhanced T1-weighted protocol to monitor the short-term changes in knee synovial lining volume in a double-blind, randomized, controlled trial of intra-articular samarium-153 particulate hydroxyapatite (Sm-153 PHYP).
METHODS:
Twenty-four out-patients with chronic knee synovitis, from a cohort who had been recruited to a long-term clinical efficacy trial, were recruited for this study. Patients received either intra-articular Sm-153 PHYP combined with 40 mg triamcinolone hexacetonide or 40 mg intra-articular triamcinolone hexacetonide alone. Synovial lining volumes were calculated from three-dimensional T1-weighted contrast-enhanced images made before and after contrast enhancement with thresholding and pixel counting, immediately before and 3 months after treatment.
RESULTS:
Paired pre- and post-treatment magnetic resonance data were obtained for 18/24 (75%) patients. There was no significant difference in mean pre-treatment synovial volume between the two treatment groups (139 vs 127 ml). A mean reduction in synovial lining volume was detected in the Sm-153 PHYP/steroid-treated group (139 to 110 ml, P = 0.07) and in the steroid-treated group (127 to 58 ml, P < 0.001). The reduction was significantly greater in the steroid-treated group (-61% vs -23%, P < 0.05).
CONCLUSIONS:
Short-term changes in articular synovial lining in response to intra-articular treatment for chronic synovitis may be monitored by magnetic resonance imaging. After 3 months, a greater mean reduction in synovial lining volume had occurred in response to intra-articular steroid alone compared to combined Sm-153 PHYP/steroid injection.
AuthorsG P Clunie, I D Wilkinson, D Lui, M A Hall-Craggs, M N Paley, J C Edwards, P J Ell
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 38 Issue 2 Pg. 113-7 (Feb 1999) ISSN: 1462-0324 [Print] England
PMID10342622 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents
  • Hydroxyapatites
  • samarium hydroxyapatite
  • Samarium
  • Triamcinolone Acetonide
  • triamcinolone hexacetonide
Topics
  • Adult
  • Anti-Inflammatory Agents (administration & dosage)
  • Chronic Disease
  • Double-Blind Method
  • Female
  • Humans
  • Hydroxyapatites (administration & dosage)
  • Knee (pathology, physiopathology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Radiography
  • Samarium (administration & dosage)
  • Synovial Membrane (diagnostic imaging, pathology)
  • Synovitis (diagnostic imaging, drug therapy, pathology)
  • Triamcinolone Acetonide (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: